Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 147   

Articles published

BMY 49.46 +0.35 (0.71%)
price chart
Bristol-Myers Squibb Co (NYSE:BMY) Unveils A New Combination To Fight HIV
Boston, MA 04/17/2014 (wallstreetpr) - Bristol-Myers Squibb Co (NYSE:BMY) said that it has filed a new drug application (NDA) with the U.S.
News Buzz-Aetna Inc (NYSE:AET), Bristol-Myers Squibb Co (NYSE:BMY ...  Techsonian (press release)
Related articles »  
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences ...
While leader Gilead Sciences (NASDAQ: GILD ) waits on the FDA review for its combination of Sovaldi and levipasvir, and battles questions over Sovaldi's price tag, Merck is producing data on easy-to-treat populations and Bristol-Myers Squibb has turned ...
Related articles »  
Bristol-Myers Squibb to Announce Results for First Quarter 2014 on April 29
Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2014 on Tuesday, April 29, 2014. During a conference call at 9 a.m.
Related articles »  
Watch List - Bristol-Myers Squibb Co (NYSE:BMY), Teva Pharmaceutical ...
Las Vegas, NV - April 19, 2013 - (Tech Sonian) ´┐ŻBristol-Myers Squibb Co (NYSE:BMY) recently declared the submission of a new drug application (NDA) on April 4, 2014 to the U.S.
Technical Pointers on Pharmaceuticals Equities -- Research on Merck, Bristol ...
Sign up today to read free research on MRK at: Shares in Bristol-Myers Squibb Co. witnessed a trading volume of 8.44 million shares on Friday, as compared with its three months average volume of ...
Related articles »  
Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to US FDA ...
PRINCETON, N.J., Apr 07, 2014 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMY) announced today that they have submitted new drug applications (NDAs) with the U.S.
Related articles »  
Ex-Dividend Reminder: Bristol-Myers Squibb, DCT Industrial Trust and Aviva
Looking at the universe of stocks we cover at Dividend Channel, on 4/2/14, Bristol-Myers Squibb Co. (NYSE: BMY), DCT Industrial Trust Inc (NYSE: DCT), and Aviva plc (NYSE: AV) will all trade ex-dividend for their respective upcoming dividends.
Bristol-Myers Squibb Submits New Drug Application to US FDA for a Fixed-Dose ...
Bristol-Myers Squibb Company (NYSE:BMY) announced today the submission of a new drug application (NDA) on April 4, 2014 to the U.S.
Bristol-Myers files for HIV-1 combo drug  Seeking Alpha
BMS Files NDA for HIV Combo Treatment  Drug Discovery & Development
Related articles »  
Healthcare Active runners: Teva Pharmaceutical Industries (NYSE:TEVA), Bristol ...
Recent deals include an agreement with Bristol-Myers Squibb Company (NYSE:BMY) to co-promote Glucophage for type II diabetes in China and another with BeiGene Co.
Related articles »  
Bristol-Myers Squibb to Present Data for Daclatasvir in Multiple ...
Bristol-Myers Squibb Company (NYSE:BMY) announced today that 12 abstracts have been accepted for presentation at The International Liver Congress(TM) , the 49(th) annual meeting of the European Association for the Study of the Liver (EASL), in London ...
Related articles »